Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07707674 |
| Title | Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Evopoint Biosciences Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| START - Midwest | Grand Rapids | Michigan | 49546 | United States | Details | |
| START - New York Long Island | Lake Success | New York | 10042 | United States | Details | |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | United States | Details | |
| Oklahoma University Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| SCRI Oncology Partners | Nashville | Tennessee | 37203 | United States | Details | |
| SCRI at Mary Crowley | Dallas | Texas | 75230 | United States | Details | |
| START - San Antonio | San Antonio | Texas | 78229 | United States | Details |